EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort

Isuru L Gamage iD, Rahul D Barmanray iD, Mervyn Kyi iD, Peter G Colman iD, Emily Sun, Minh V Le iD, Leon J Worth iD, Spiros Fourlanos

The Journal of Clinical Endocrinology & Metabolism · 21.01.2026 · 111 (2) · e375-e381

DOI: 10.1210/clinem/dgaf440 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.08.2025. Verfasst von Isuru L Gamage und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia. Hauptthemen laut MEDLINE: Glycemic Control, Hyperglycemia, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Rowe Family Foundation Perpetual Grant, The Royal Melbourne Hospital Home Lottery Victor Hurley, Australian Government Research Training Program Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the effect of an early, electronic specialist-led model of inpatient diabetes care on glycemic outcomes following discharge and rates of treatment intensification.

Methods

The STOIC-D trial has demonstrated early, electronic specialist-led care by an inpatient diabetes service reduces inpatient hyperglycemia. This follow-up study assessed glycemic outcomes following discharge in a subgroup of 360 STOIC-D trial patients with admission glycated hemoglobin (HbA1c) ≥ 7% and alive 1 year following hospitalization. First available HbA1c between 3 and 15 months following discharge was collected. Multivariable logistic regression identified predictors of clinically significant reduction in HbA1c, defined as ≥0.5%. Multivariable linear regression assessed correlation of baseline characteristics with change in HbA1c. Multivariable logistic regression identified predictors of treatment intensification in hospital.

Results

The early intervention arm experienced a greater HbA1c reduction following hospitalization (0.4% [3.9 mmol/mol] vs -0.04% [-0.4 mmol/mol]) compared with preadmission (P = .02). Clinically significant reduction in HbA1c occurred more frequently in the intervention arm (45% vs 31% [P = .01], adjusted odds ratio [aOR] 1.8; 95% CI, 1.1-2.9). Adjusted multivariable linear regression demonstrated inclusion in the intervention arm correlated with proportional reduction in posthospitalization HbA1c. Treatment intensification was more common in the intervention compared with control (36% vs 19% [P = .002], aOR 2.2 [95% CI: 1.3-3.6]). In a subanalysis of participants with admission HbA1c of 7% to 8.5%, age <75 years, the aOR for treatment intensification with early intervention was 4.0 (95% CI, 1.6-11.1).

Conclusion

Treatment intensification and posthospitalization HbA1c improved following intervention with an early, electronic specialist-led consultation in hospital.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycemic ControlHyperglycemiaDiabetes Mellitus, Type 2HumansMaleFemaleMiddle AgedFollow-Up StudiesGlycated HemoglobinAgedBlood GlucosePatient DischargeHospitalization

Stichwörter der Autor:innen

diabetes mellitusglycemic controlhyperglycemia managementinpatient diabetes

Substanzen

Glycated HemoglobinBlood Glucosehemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
  • Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria 3050, Australia.
  • Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
  • National Centre for Infections in Cancer (NCIC), Sir Peter MacCallum Department of Oncology, The University of Melbourne, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
  • Victorian Healthcare Associated Infection Surveillance System (VICNISS) Coordinating Centre, Doherty Institute, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.

ORCID-Profile: Isuru L Gamage, Rahul D Barmanray, Mervyn Kyi, Peter G Colman, Minh V Le, Leon J Worth

Förderung

  • Rowe Family Foundation Perpetual Grant
  • The Royal Melbourne Hospital Home Lottery Victor Hurley
  • Australian Government Research Training Program Scholarship

Zitieren

APA

Gamage, I. L., Barmanray, R. D., Kyi, M., Colman, P. G., Sun, E., Le, M. V., Worth, L. J., & Fourlanos, S. (2026). Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort. The Journal of Clinical Endocrinology & Metabolism, 111(2), e375-e381. https://doi.org/10.1210/clinem/dgaf440

Vancouver

Gamage IL, Barmanray RD, Kyi M, Colman PG, Sun E, Le MV, et al. Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort. The Journal of Clinical Endocrinology & Metabolism. 2026;111(2):e375-e381. doi:10.1210/clinem/dgaf440

BibTeX
@article{Gamage2026,
  author = {Gamage, Isuru L and Barmanray, Rahul D and Kyi, Mervyn and Colman, Peter G and Sun, Emily and Le, Minh V and Worth, Leon J and Fourlanos, Spiros},
  title = {Early Electronic Specialist-led Diabetes Care Improves Postdischarge Glycemia: The STOIC-D Surgery Follow-up Cohort},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {2},
  pages = {e375--e381},
  doi = {10.1210/clinem/dgaf440}
}
Kostenlos starten →